Study of the Hummingbird TTS™ Tympanostomy Tube System

Overview

The objective of this study was continued commercial evaluation of the intraoperative safety and performance of the H-TTS for the placement of ventilation tubes in pediatric patients undergoing a tympanostomy procedure under moderate sedation and local anesthetic.

Full Title of Study: “Post-Market Surveillance Study of the Preceptis Medical, Inc. Hummingbird TTS™ Tympanostomy Tube System”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: August 2021

Detailed Description

The study was a multi-site, prospective and retrospective, treatment-only post-market study of the H-TTS. The study was performed in a commercial environment. Patients were already have a scheduled tympanostomy procedure with the H-TTS under moderate sedation and local anesthetic.

Interventions

  • Device: Hummingbird Tympanostomy Tube System
    • Insertion of a ventilation tube under sedation and local anesthetic

Clinical Trial Outcome Measures

Primary Measures

  • Percentage of Procedures Converted From Sedation to General Anesthesia
    • Time Frame: Intra-operative
    • Percentage of procedures that require conversion from sedation to general anesthesia
  • Rate of Intra-operative Adverse Events
    • Time Frame: Intra-operative
    • Rate of intra-operative adverse events that occur from the beginning to the end of the procedure
  • Rate of Adverse Events Through Discharge
    • Time Frame: Through discharge, estimated to be approximately 90 minutes post-procedure
    • Rate of adverse events that occur between the end of the procedure and discharge

Participating in This Clinical Trial

Inclusion Criteria

  • Age 6 months through 5 years of age – Candidates for ventilation tube placement – H-TTS used under moderate sedation and local anesthetic

Gender Eligibility: All

Minimum Age: 6 Months

Maximum Age: 5 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Preceptis Medical, Inc.
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.